Literature DB >> 21689241

Systemic treatment for alopecia areata.

Nina Otberg1.   

Abstract

Of the world population, 1.7% is suffering from alopecia areata at some point in their lives. The exact etiology of this disease is still unknown, and the course of the disease is unpredictable. Effective treatments, especially for severe multifocal alopecia areata, alopecia areata totalis, and alopecia areata universalis, are lacking. The present article will discuss side effects and relapse rates of different systemic agents for treatment of severe and rapid progressive alopecia areata.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21689241     DOI: 10.1111/j.1529-8019.2011.01420.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  4 in total

1.  [Alopecia areata].

Authors:  V von Felbert; H F Merk
Journal:  Hautarzt       Date:  2013-11       Impact factor: 0.751

2.  Evaluation of fractional carbon dioxide laser alone versus its combination with betamethasone valerate in treatment of alopecia areata, a clinical and dermoscopic study.

Authors:  Dalia Abdel Halim; Mariam Nayer; Solwan Ibrahim El-Samanoudy; Heba Mohamed Abdel Raheem; Nanis Ragab
Journal:  Arch Dermatol Res       Date:  2022-09-17       Impact factor: 3.033

Review 3.  New aspects of the treatment of alopecia areata.

Authors:  Ligia Brzezińska-Wcisło; Beata Bergler-Czop; Dominika Wcisło-Dziadecka; Anna Lis-Święty
Journal:  Postepy Dermatol Alergol       Date:  2014-09-08       Impact factor: 1.837

4.  Early intervention with high-dose steroid pulse therapy prolongs disease-free interval of severe alopecia areata: a retrospective study.

Authors:  Chao-Chun Yang; Chun-Te Lee; Chao-Kai Hsu; Yi-Pei Lee; Tak-Wah Wong; Sheau-Chiou Chao; Julia Yu-Yun Lee; Hamm-Ming Sheu; Wenchieh Chen
Journal:  Ann Dermatol       Date:  2013-11-30       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.